A Palliative Ethic of Care) and honoraria from conferences with mosaic funding but no direct honoraria from the pharmaceutical industry. He discloses ownership of a diversified biotech mutual fund but no tobacco or pharmaceutical stocks. He discloses that he was previously an uncompensated investigator of DBS in an MCS study for Intelect Medical, Inc. Reviewer "A" discloses employment with Massachusetts General Hospital and Harvard, a consulting relationship with and honoraria received from sanofi-aventis, Redwood Pharmaceuticals, Allergan, Epizyme, PharmaMar, and GlaxoSmithKline, research funding from the U.S. government, and ownership interests with PharmaMar and Gilead Sciences. The content of this article has been reviewed by independent peer reviewers to ensure that it is balanced, objective, and free from commercial bias. On the basis of disclosed information, all conflicts of interest have been resolved.
LEARNING OBJECTIVESAfter completing this course, the reader will be able to:1. Act as a role model to promote patient and community health by abstaining from or quitting smoking and encouraging and assisting patients and colleagues to quit smoking.2. Assume more responsibility for advocating for smoke-free environments and policies that combat smokingrelated health threats in the community.3. Actively support international policies and interventions that expand tobacco cessation and smoke-free environments.This article is available for continuing medical education credit at CME.TheOncologist.com. The Oncologist CME Program is located online at http://cme.theoncologist.com/. To take the CME activity related to this article, you must be a registered user.
CME CME
ABSTRACT
Medical EthicsThe